Novocure
NVCR
#3878
Rank
$2.31 B
Marketcap
Jersey
Country
$21.50
Share price
-2.93%
Change (1 day)
-55.82%
Change (1 year)
Categories
Novocure (NVCR) - P/B ratio
P/B ratio as of June 2024 : 6.44
According to Novocure
's latest financial reports the company has a price-to-book ratio of 6.44.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Novocure - P/B ratio (from 2015 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 4.40 | -74.78% |
| 2022-12-31 | 17.4 | -8.11% |
| 2021-12-31 | 19.0 | -48.63% |
| 2020-12-31 | 37.0 | -4.01% |
| 2019-12-31 | 38.5 | 38.47% |
| 2018-12-31 | 27.8 | 74.97% |
| 2017-12-31 | 15.9 | 232.14% |
| 2016-12-31 | 4.79 | -35.92% |
| 2015-12-31 | 7.47 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | 2.20 | -65.87% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | 4.74 | -26.44% | 🇬🇧 UK |
 Novavax NVAX | -3.06 | -147.47% | 🇺🇸 USA |
 Novocure
NVCR | 6.44 | 0.00% | Jersey |